Literature DB >> 32483373

C9orf72 suppresses systemic and neural inflammation induced by gut bacteria.

Aaron Burberry1,2, Michael F Wells1,2, Francesco Limone1,2,3, Alexander Couto1,2, Kevin S Smith1,2, James Keaney4, Gaëlle Gillet4, Nick van Gastel1,5, Jin-Yuan Wang1,2, Olli Pietilainen1,2, Menglu Qian1,2,6, Pierce Eggan1,2, Christopher Cantrell1,2, Joanie Mok1,2, Irena Kadiu4, David T Scadden1,5, Kevin Eggan7,8,9.   

Abstract

A hexanucleotide-repeat expansion in C9ORF72 is the most common genetic variant that contributes to amyotrophic lateral sclerosis and frontotemporal dementia1,2. The C9ORF72 mutation acts through gain- and loss-of-function mechanisms to induce pathways that are implicated in neural degeneration3-9. The expansion is transcribed into a long repetitive RNA, which negatively sequesters RNA-binding proteins5 before its non-canonical translation into neural-toxic dipeptide proteins3,4. The failure of RNA polymerase to read through the mutation also reduces the abundance of the endogenous C9ORF72 gene product, which functions in endolysosomal pathways and suppresses systemic and neural inflammation6-9. Notably, the effects of the repeat expansion act with incomplete penetrance in families with a high prevalence of amyotrophic lateral sclerosis or frontotemporal dementia, indicating that either genetic or environmental factors modify the risk of disease for each individual. Identifying disease modifiers is of considerable translational interest, as it could suggest strategies to diminish the risk of developing amyotrophic lateral sclerosis or frontotemporal dementia, or to slow progression. Here we report that an environment with reduced abundance of immune-stimulating bacteria10,11 protects C9orf72-mutant mice from premature mortality and significantly ameliorates their underlying systemic inflammation and autoimmunity. Consistent with C9orf72 functioning to prevent microbiota from inducing a pathological inflammatory response, we found that reducing the microbial burden in mutant mice with broad spectrum antibiotics-as well as transplanting gut microflora from a protective environment-attenuated inflammatory phenotypes, even after their onset. Our studies provide further evidence that the microbial composition of our gut has an important role in brain health and can interact in surprising ways with well-known genetic risk factors for disorders of the nervous system.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32483373      PMCID: PMC7416879          DOI: 10.1038/s41586-020-2288-7

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  3 in total

1.  Efficacy of direct detection of pathogens in naturally infected mice by using a high-density PCR array.

Authors:  Kenneth S Henderson; Cheryl L Perkins; Richard B Havens; Mee-Jin E Kelly; Brian C Francis; Vandana S Dole; William R Shek
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-11       Impact factor: 1.232

Review 2.  Natural and experimental Helicobacter infections.

Authors:  Mark T Whary; James G Fox
Journal:  Comp Med       Date:  2004-04       Impact factor: 0.982

3.  Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing.

Authors:  Xin Fang; Xin Wang; Shaoguo Yang; Fanjing Meng; Xiaolei Wang; Hua Wei; Tingtao Chen
Journal:  Front Microbiol       Date:  2016-09-20       Impact factor: 5.640

  3 in total
  52 in total

1.  Arginine-rich dipeptide-repeat proteins as phase disruptors in C9-ALS/FTD.

Authors:  Hana M Odeh; James Shorter
Journal:  Emerg Top Life Sci       Date:  2020-12-11

Review 2.  Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy.

Authors:  Naoki Suzuki; Ayumi Nishiyama; Hitoshi Warita; Masashi Aoki
Journal:  J Hum Genet       Date:  2022-06-13       Impact factor: 3.172

Review 3.  Modelling amyotrophic lateral sclerosis in rodents.

Authors:  Tiffany W Todd; Leonard Petrucelli
Journal:  Nat Rev Neurosci       Date:  2022-03-08       Impact factor: 34.870

Review 4.  The Microbiome as a Modifier of Neurodegenerative Disease Risk.

Authors:  P Fang; S A Kazmi; K G Jameson; E Y Hsiao
Journal:  Cell Host Microbe       Date:  2020-08-12       Impact factor: 21.023

Review 5.  Gut microbiome, liver immunology, and liver diseases.

Authors:  Rui Wang; Ruqi Tang; Bo Li; Xiong Ma; Bernd Schnabl; Herbert Tilg
Journal:  Cell Mol Immunol       Date:  2020-12-14       Impact factor: 11.530

Review 6.  Cellular and physiological functions of C9ORF72 and implications for ALS/FTD.

Authors:  Weilun Pang; Fenghua Hu
Journal:  J Neurochem       Date:  2020-12-18       Impact factor: 5.372

7.  Colonization of the Caenorhabditis elegans gut with human enteric bacterial pathogens leads to proteostasis disruption that is rescued by butyrate.

Authors:  Alyssa C Walker; Rohan Bhargava; Alfonso S Vaziriyan-Sani; Christine Pourciau; Emily T Donahue; Autumn S Dove; Michael J Gebhardt; Garrett L Ellward; Tony Romeo; Daniel M Czyż
Journal:  PLoS Pathog       Date:  2021-05-06       Impact factor: 6.823

8.  Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis.

Authors:  Felipe Papa Pellizoni; Aline Zazeri Leite; Nathália de Campos Rodrigues; Marcelo Jordão Ubaiz; Marina Ignácio Gonzaga; Nauyta Naomi Campos Takaoka; Vânia Sammartino Mariano; Wellington Pine Omori; Daniel Guariz Pinheiro; Euclides Matheucci Junior; Eleni Gomes; Gislane Lelis Vilela de Oliveira
Journal:  Int J Environ Res Public Health       Date:  2021-04-27       Impact factor: 3.390

Review 9.  Overlapping mechanisms of lncRNA and expanded microsatellite RNA.

Authors:  Sara J Johnson; Thomas A Cooper
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-11-16       Impact factor: 9.957

Review 10.  Gut microbiota and systemic immunity in health and disease.

Authors:  Bernard C Lo; Grace Y Chen; Gabriel Núñez; Roberta Caruso
Journal:  Int Immunol       Date:  2021-03-31       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.